Skip to main content
. 2019 Dec 17;20(24):6354. doi: 10.3390/ijms20246354

Figure 1.

Figure 1

Proteasomal activity of the chymotrypsin-like (A) and trypsin-like (B) catalytic domains in myocardial tissue from control (n = 11), ischemic cardiomyopathy (ICM) (n = 19), and dilative cardiomyopathy (DCM) (n = 22) patients. Results are expressed as mean ± SEM.